Originally published In Press as doi:10.1074/jbc.M001563200 on April 27, 2000
J. Biol. Chem., Vol. 275, Issue 29, 22229-22237, July 21, 2000
Regulation of F-actin and Endoplasmic Reticulum Organization
by the Trimeric G-protein Gi2 in Rat Hepatocytes
IMPLICATION FOR THE ACTIVATION OF STORE-OPERATED
Ca2+ INFLOW*
Ying-Jie
Wang
,
Roland B.
Gregory, and
Greg J.
Barritt§
From the Department of Medical Biochemistry, School of Medicine,
Faculty of Health Sciences, Flinders University, GPO Box 2100, Adelaide, South Australia 5001, Australia
Received for publication, February 25, 2000, and in revised form, April 14, 2000
 |
ABSTRACT |
The roles of the heterotrimeric G-protein,
Gi2, in regulating the actin cytoskeleton and the
activation of store-operated Ca2+ channels in rat
hepatocytes were investigated. G
i2 was principally associated with the plasma membrane and microsomes. Both F-actin and
G
i2 were detected by Western blot analysis in a purified plasma membrane preparation, the supernatant and pellet obtained by
treating the plasma membrane with Triton X-100, and after
depolymerization and repolymerization of F-actin in the Triton
X-100-insoluble pellet. Actin in the Triton X-100-soluble supernatant
co-precipitated with G
i2 using either
anti-G
i2 or anti-actin antibodies. The principally
cortical location of F-actin in hepatocytes cultured for 0.5 h
changed to a pericanalicular distribution over a further 3.5 h.
Some G
i2 co-localized with F-actin at the plasma
membrane. Pretreatment with pertussis toxin ADP-ribosylated 70-80% of
G
i2 in the plasma membrane and microsomes, prevented the
redistribution of F-actin, caused redistribution and fragmentation of
the endoplasmic reticulum, and inhibited vasopressin-stimulated
Ca2+ inflow. It is concluded that (i) a significant portion
of hepatocyte G
i2 associates with, and regulates the
arrangement of, cortical F-actin and the endoplasmic reticulum and (ii)
either or both of these regulatory roles are likely to be required for
normal vasopressin activation of Ca2+ inflow.
 |
INTRODUCTION |
In most nonexcitable and in some excitable cells, depletion of the
inositol 1,4,5-trisphosphate
(InsP3)1-sensitive
intracellular Ca2+ stores in the endoplasmic reticulum (ER)
activates a Ca2+ influx pathway, a process known as
store-operated Ca2+ influx or capacitative Ca2+
entry (1). Although it has been widely accepted that the key event
initiating the opening of store-operated Ca2+ channels
(SOCs) in the plasma membrane is the decrease in the concentration of
Ca2+ in the lumen of the ER, neither the mechanism that
couples these two events nor the structures of SOCs are well understood
(2). The results of recent experiments indicate that an essential
prerequisite for the activation of SOCs is the close association
between regions of the ER and the plasma membrane (3). It is proposed
that this association is maintained by cytoskeletal elements such as the F-actin (4). There is evidence that, in some cell types, dismantling of the F-actin cytoskeleton (5), stabilization of the
F-actin cytoskeleton (6), or inhibition of myosin light chain kinase
(7) blocks Ca2+ influx via SOCs while leaving
Ca2+ release from the intracellular stores unaffected (but
see Ref. 8).
Hepatocytes are polarized epithelial cells in which the F-actin
cytoskeleton is distributed around the cortex, with a high concentration at the pericanalicular (apical) region (9). This cortical
F-actin may play a role in maintaining subregions of the ER close to
the plasma membrane (4). Evidence, including results obtained with a
microinjected inhibitory anti-G
i2 antibody, indicates
that the activation of SOCs in hepatocytes requires the trimeric
G-protein Gi2 (10) and a brefeldin A-sensitive protein,
possibly a monomeric G-protein (11). It has been reported that some
G
i2 co-localizes with F-actin in hepatocytes in primary culture (12). Moreover, studies with other cell types have provided evidence for an association between G
i2 and F-actin
(13-15), and have suggested a potential role for G
i2 in
organization of the F-actin cytoskeleton (16-18). On the basis of
these observations, we proposed that Gi2 may regulate
arrangement of the actin cytoskeleton and the arrangement of the ER by
which both the intimate plasma membrane-ER association is achieved and
the communication between different parts of the ER is maintained and
allows the activation of SOCs.
The aims of the present experiments were to elucidate the role of
Gi2 in the activation of SOCs in hepatocytes by
investigating the intracellular distribution of G
i2 and
F-actin, the association of G
i2 with F-actin, and the
requirement for G
i2-F-actin interaction in regulation of
the arrangement of F-actin and in the activation of SOCs. The results
indicate that a significant proportion of the cellular
G
i2 is associated with F-actin and regulates F-actin organization (especially the cortical actin layer near the canalicular membrane) and the arrangement of the ER. To our knowledge, this is the
first demonstration of the role of G
i2 in regulating the arrangement of F-actin in an epithelial cell type. Taken together with
previous evidence that the normal function of G
i2 is
required for the activation of SOCs in rat hepatocytes (10), these
observations suggest that G
i2, either through regulation
of cortical F-actin organization and/or arrangement of the ER, allows
the normal activation of SOCs.
 |
EXPERIMENTAL PROCEDURES |
Materials--
Affinity-purified rabbit polyclonal
anti-G
i antibody, raised against the C-terminal
decapeptide (KENLKDCGLF) of the
-subunit of transducin, was kindly
provided by Dr. Michael Crouch (John Curtin School of Medical Research,
Australian National University, Canberra, Australia). Although this
antibody detects both G
i1 and G
i2, liver
does not express detectable G
i1 (19, 20), so that the
G-protein detected by this antibody in the present experiments is
G
i2. Peptides KENLKDCGLF and QLNLKEYNLV, synthesized as
described in Ref. 10, were provided by Dr. Bruce Kemp (St. Vincent's
Institute of Medical Research, Victoria, Australia). Purified
phosphoprotein phosphatases 1 and 2A were kind gifts from Dr. Alistair
Sim (University of Newcastle, Australia). Pertussis toxin,
affinity-purified rabbit polyclonal anti-actin antibody, goat
anti-rabbit IgG conjugated to alkaline phosphatase, actin standard for
Western blotting, protein A-Sepharose, Triton X-100, nitro blue
tetrazolium, and bromochloroindolyl phosphate were from Sigma, and
Texas Red-X phalloidin, 3,3'-dihexyloxacarbocyanine iodide
(DiOC6(3)), fura-2, and goat anti-rabbit IgG
conjugated to AlexaTM 488 were from Molecular Probes, Inc.
(Eugene, OR). Recombinant G
i2 protein was from
Calbiochem (Alexandria, Australia). All other chemicals and
materials were of the highest grade commercially available.
Western Blot Analysis of G
i2 and
Actin--
SDS-PAGE was performed on 12% polyacrylamide resolving
gels with the Laemmli discontinuous buffer system (21), and the
resolved proteins were electrotransferred to nitrocellulose membranes
by the method of Towbin et al. (22). Membranes were blocked
with 1 M glycine containing 5% (w/v) nonfat milk powder,
5% (v/v) fetal calf serum, and 1% (w/v) ovalbumin for 1 h at
room temperature and then washed three times (5 min each) at room
temperature with 0.1% (v/v) Tween 20, 0.1% (w/v) nonfat milk powder,
and 0.1% (w/v) ovalbumin dissolved in 137 mM NaCl, 2.7 mM KCl, 8 mM Na2HPO4, and 1.4 mM KH2PO4 (pH 7.2).
Membranes were incubated overnight at 4 °C with either
anti-G
i antibody (1:200 dilution in the above wash
buffer) or anti-actin antibody (1:100 dilution) or, in some cases, both
antibodies together followed by incubation with secondary antibody
(goat anti-rabbit IgG conjugated to alkaline phosphatase, 1:1000
dilution) for 2 h at room temperature and finally developed for 5 min in 100 mM Tris-HCl (pH 9.5), 100 mM NaCl,
and 5 mM MgCl2 containing 0.33 mg/ml nitro blue
tetrazolium and 0.16 mg/ml bromochloroindolyl phosphate. Quantitation
of the bands was performed on a Bio-Rad model GS-700 imaging
densitometer driven by the Molecular Analyst software package
(Bio-Rad). SDS-PAGE in the presence of 6 M urea was
conducted as described by Komatsu et al. (23).
Subcellular Fractionation and Marker Enzyme Assays--
Rat
livers were homogenized in a medium containing 250 mM
sucrose, 5 mM HEPES/KOH (pH 7.4), and 1 mM EGTA
(homogenization medium), supplemented with 1 mM
dithiothreitol, 0.2 mM phenylmethanesulfonyl fluoride, 10 µg/ml leupeptin, and 10 µg/ml pepstatin A (protease inhibitor
mixture) and subcellular fractions prepared by differential centrifugation (24), with the 100,000 × g supernatant
being designated the "cytosolic fraction." A purified plasma
membrane fraction and a nuclei-contaminated plasma membrane fraction
were prepared by Percoll gradient centrifugation (25). Protein
concentrations were determined by the Bradford method (26) with bovine
serum albumin as a standard. The activities of the marker enzymes
5'-nucleotidase (plasma membrane) and glucose-6-phosphatase (ER) were
determined as described by Aronson and Touster (27).
Treatment of a Liver Cytosolic Fraction with Phosphoprotein
Phosphatases--
The liver cytosolic fraction (100 µl) was diluted
with an equivalent volume of homogenization medium supplemented with
1% (w/v) Triton X-100, 1 mM dithiothreitol, and the
protease inhibitor mixture. Either 5 µl (5 units; 1 unit of the
enzyme is defined as the amount that hydrolyzes 1 nmol of phosphate
from the phosphorylated proteins per min at 30 °C, pH 7.0) of
phosphoprotein phosphatase 1 or 5 µl (5 units) of phosphoprotein
phosphatase 2A or 5 µl of vehicle (control) was added to 25 µl of
the above diluted cytosolic extract. The mixture was incubated at
37 °C for 1 h, mixed with 30 µl of Laemmli sample buffer,
boiled, and subjected to SDS-PAGE and Western blotting analysis.
Triton X-100 Extraction of the Plasma Membrane Fraction to Yield
a Triton X-100-insoluble Pellet and a Triton X-100-soluble Supernatant
and Preparation of a Repolymerized F-actin Fraction from the Plasma
Membrane Triton X-100-Insoluble Pellet--
Plasma membrane pellets
were resuspended in lysis buffer, which consisted of 50 mM
HEPES (pH 7.4), 1% (w/v) Triton X-100, 150 mM NaCl, 1 mM EGTA, 1 mM Na3VO4,
100 mM NaF, 10 mM
Na4P2O7, 10% (w/v) glycerol,
supplemented with the protease inhibitor mixture, and incubated on ice
for 1 h. A Triton X-100-insoluble pellet and a Triton
X-100-soluble supernatant were obtained by centrifugation at
14,000 × g for 10 min. F-actin present in the plasma
membrane Triton X-100-insoluble pellet was subjected to two cycles of
depolymerization and repolymerization as described by Ueda et
al. (15), and the final fraction was called the "repolymerized
F-actin fraction." All fractions were quantitatively mixed with
Laemmli sample buffer for Western blot analysis.
Immunoprecipitation--
The plasma membrane Triton
X-100-soluble supernatant prepared as described above was incubated on
ice for 2 h with either an anti-G
i or an anti-actin
antibody or with normal rabbit serum (as control). Samples were mixed
with swollen protein A-Sepharose (5 mg, dry weight), and the incubation
continued for a further 1 h. Immune complexes bound to protein
A-Sepharose were collected by centrifugation (12,000 × g, 1 min). The pellets were washed three times in 0.2 M NaCl, 50 mM Tris-HCl (pH 7.4), resuspended in
Laemmli sample buffer, boiled for 5 min, and centrifuged (12,000 × g, 1 min), and the supernatant was retained for SDS-PAGE
and Western blotting analysis.
Treatment of Rats with Pertussis Toxin and Isolation and Culture
of Hepatocytes--
Pertussis toxin (25 µg in 50 mM
Tris, pH 7.5, 10 mM glycine, 0.5 M NaCl, 50%
(v/v) glycerol/100 g of body weight) or vehicle was administered to
Hooded Wistar rats by intraperitoneal injection (28). After 24 h,
hepatocytes were isolated by collagenase perfusion (29) and grown in
primary culture on type I collagen-coated coverslips (30).
The Localization of the F-actin Cytoskeleton, G
i2,
and the Endoplasmic Reticulum--
The locations of the F-actin and ER
were determined using Texas Red-X phalloidin and DiOC6(3),
respectively, and confocal microscopy as described previously (31).
Negative controls for ER and F-actin staining were carried out
systematically by omitting DiOC6(3) and Texas Red-X
phalloidin, respectively. Determination of the location of
G
i2 by immunofluorescence was performed as described
previously (10). Controls were performed by omitting either the primary
antibody or the secondary antibody or both and by incubating the
primary antibody with excess blocking peptide before use.
For double labeling of F-actin and G
i2 in the same cell,
F-actin staining was first performed as described above. The cells were
then washed with phosphate-buffered saline containing 0.05% (v/v)
Tween 20 and 1% (w/v) bovine serum albumin (Tween solution) and
incubated overnight at 4 °C with anti-G
i antibody (5 µg/ml in Tween solution). Thereafter, cells were washed six times
with the Tween solution, incubated with secondary antibody
(AlexaTM 488-conjugated goat anti-rabbit IgG, 1:100
dilution in Tween solution), and washed twice with Tween solution and
four times with phosphate-buffered saline before the coverslips were
mounted on slides in 50% glycerol in phosphate-buffered saline.
Confocal microscopy was performed using a Bio-Rad MRC-1000
laser-scanning confocal microscope system in combination with a Nikon
Diaphot 300 inverted microscope and a × 40 NA 1.15 water immersion objective lens. The excitation and emission wavelengths were
set at 568/10 and 605/35 nm, respectively, for Texas Red-X, and at
488/10 and 522/32 nm, respectively, for DiOC6(3) and
AlexaTM 488. To standardize the fluorescence intensity
measurements among experiments, the time of image capturing, the image
intensity gain, the image enhancement, and the image black level were
optimally adjusted at the outset and kept constant for each of Texas
Red-X, DiOC6(3), and AlexaTM 488. In most
cases, only images of the optical sections near the middle of the
z axis were collected.
Quantitative examination of the captured images was performed using
CoMOS (Bio-Rad) image analysis software. To quantitate F-actin
distribution, for each experimental condition, 60 hepatocyte doublets
were randomly selected from the images obtained from three separate
cell preparations (20 doublets from each preparation), and the
fluorescence (pixels) in the total doublet and in the pericanalicular
area was measured. The fluorescence in the pericanalicular area was
expressed as a percentage of the total doublet fluorescence. This
percentage indicates the relative amount of F-actin around the bile
canaliculus and hence the degree of reorganization of F-actin during
primary culture (cf. Ref. 32). To avoid the subjectivity of
this measurement, it was verified that the elliptical area designated
as "pericanalicular area" occupied 9.95 ± 0.06% (mean ± S.E., n = 60) of the total area of control doublets
and 9.92 ± 0.06% (mean ± S.E., n = 60) of
the total area of pertussis toxin-treated doublets, respectively.
Electron Microscopy--
Pellets (3000 × g for
2 min) of the plasma membrane fraction (~1 mg) were fixed in 1 ml of
1% (w/v) glutaraldehyde in 25 mM HEPES buffer (pH 7.4) for
30 min on ice. After washing three times with 25 mM HEPES
buffer, the samples were postfixed with 1% (w/v) OsO4 in
the same HEPES buffer for 1 h on ice. Freshly isolated intact
hepatocytes (pelleted by centrifugation at 80 × g for
30 s) were fixed for 2 h at room temperature in a solution
containing 1% (w/v) OsO4 and 0.1 M
Na2HPO4/NaH2PO4 (pH
7.4). Fixed samples were dehydrated by stepwise exposure to increasing
concentrations of ethanol (50, 75, 85, 95, and 100% (v/v)) and
embedded in Durcupan with propylene oxide as an intermediate transition
medium. The ultrathin sections were cut on an ultramicrotome, stained
with aqueous uranyl acetate and Reynold's lead citrate, and examined with a JEOL 1200 EX transmission electron microscope.
Measurement of Ca2+ Inflow--
Cytoplasmic free
Ca2+ concentrations ([Ca2+]cyt)
and initial rates of Ca2+ inflow (measured using a
Ca2+ add-back protocol) in rat hepatocytes loaded with
fura-2 by microinjection were determined using fluorescence microscopy
(31).
 |
RESULTS |
Nature and Distribution of G
i2 in Rat Liver
Subcellular Fractions--
When rat liver homogenates were subjected
to Western blot analysis, two forms of G
i2, with
apparent molecular masses of 41 and 43 kDa, were detected (Fig.
1A). The plasma membrane
fraction contained predominantly the 41-kDa band, which co-migrated
with recombinant G
i2 (Fig. 1B,
lanes 1 and 2), while the cytosolic fraction contained predominantly the 43-kDa band (Fig. 1B,
lanes 3 and 4). Treatment of cytosolic
fraction with phosphoprotein phosphatase 1 converted the 43-kDa form of
G
i2 to a form that co-migrates with recombinant
G
i2 (Fig. 1C, lanes 1,
2, and 5). By contrast, treatment with
phosphoprotein phosphatase 2A did not alter the mobility of the 43-kDa
band (Fig. 1C, lanes 1, 3, and 6). These results indicate that (i) the 41-kDa form of
G
i2 (subsequently referred to as G
i2)
corresponds to the form of G
i2 (nonphosphorylated)
normally detected in most cell types and (ii) the species of
G
i2 with an apparent molecular mass of 43 kDa
(subsequently referred to as phosphorylated G
i2) is a phosphorylated form of G
i2 (cf. Ref. 33).

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 1.
Western blot analysis of
G i2 present in whole liver
homogenate (A), plasma membrane and cytosolic
fractions (B), and after treatment with phosphoprotein
phosphatases (C). A, whole liver.
Samples of rat liver homogenate were subjected to SDS-PAGE (15 µg of
protein/lane) and Western blot analysis using anti-G i
antibody (lane 1), anti-G i
antibody mixed with immunizing peptide KENLKDCGLF (100 µg/ml)
(lane 2), or anti-G i antibody
mixed with an unrelated decapeptide QLNLKEYNLV (100 µg/ml)
(lane 3). The results shown are from one of three
experiments that gave similar results. B, plasma membrane
and cytosolic fractions. Lane 1, plasma membrane
fraction (15 µg of protein); lane 2, plasma
membrane fraction mixed with recombinant G i2 (2 µl);
lane 3, cytosolic fraction (15 µg of protein);
lane 4, cytosolic fraction mixed with recombinant
G i2 (2 µl). Samples were subjected to SDS-PAGE and
Western blotting using anti-G i antibody. The results
shown are from one of three experiments that gave similar results.
C, the effect of treatment of the liver cytosolic fraction
with phosphoprotein phosphatases on the mobility of the 43-kDa
G i2 band. The cytosolic extract was treated with
phosphoprotein phosphatase 1 or 2A as described under "Experimental
Procedures." Samples were subjected to SDS-PAGE and Western blot
analysis using anti-G i antibody as the probe.
Lane 1, cytosolic extract; lane
2, cytosolic extract treated with phosphoprotein phosphatase
1; lane 3, cytosolic extract treated with
phosphoprotein phosphatase 2A; lane 4, cytosolic
extract plus recombinant G i2; lane
5, cytosolic extract treated with phosphoprotein phosphatase
1 plus recombinant G i2; lane 6,
cytosolic extract treated with phosphoprotein phosphatase 2A plus
recombinant G i2. The results shown are from one of two
experiments that gave similar results.
|
|
G
i2 was found in the plasma membrane, the nuclear-plasma
membrane, and the heavy and light microsomal fractions of the liver (Fig. 2A) but was barely
detectable in the cytosolic fraction. The amount of G
i2
associated with the microsomes was estimated to be 40% of total
cellular G
i2. G
i2 (41-kDa) was the
predominant form of G
i2 found in the plasma membrane and
the nuclear plasma membrane fractions. Phosphorylated
G
i2 was principally found in the cytosolic fraction, but
some was also associated with the heavy and light microsomes (Fig.
2A). In order to determine how tightly G
i2 is
associated with the microsomal membranes, the microsomes were treated
with KCl, which has been shown to cause the dissociation of loosely
bound proteins from liver microsomal membranes (34). Phosphorylated
G
i2, but not the non-phosphorylated form, could be
removed from microsomes by treatment with KCl (Fig. 2B).
These results indicate that G
i2 is tightly associated
with microsomal vesicles, whereas phosphorylated G
i2 is
only loosely associated.

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 2.
Western blot analysis of the 41- and 43-kDa
forms of G i2 present in rat liver
subcellular fractions (A) and before and after washing
microsomal fractions with KCl (B). A,
the distribution of 41- and 43-kDa G i2 in subcellular
fractions prepared from rat liver assessed by Western blot analysis
using an anti-G i antibody. The protein amount of each
fraction applied to the gel was 15 µg. The results shown are from one
of six experiments that gave similar results. B, the effect
of washing the microsomal fractions with KCl on the amount of
G i2 associated with the microsomes. The heavy and light
microsomal pellets were suspended in ice-cold homogenization medium
supplemented with 0.15 M KCl (final concentration),
incubated on ice for 5 min, and centrifuged (30 min at 35,000 × g for KCl-treated heavy microsomes, and 60 min at
100,000 × g for KCl-treated light microsomes). The
resulting pellets were resuspended in wash medium, quantitatively
dissolved in Laemmli sample buffer, and subjected to SDS-PAGE (15 µg
of protein/lane) and Western blot analysis using anti-G i
antibody as a probe. The results shown are from one of two experiments
that gave similar results.
|
|
The distribution of the phosphorylated and nonphosphorylated forms of
G
i2 within hepatocytes was further analyzed by
determining the degrees of enrichment of the liver subcellular
fractions in the two forms of G
i2, 5'-nucleotidase (a
plasma membrane marker enzyme) and glucose 6-phosphatase (an ER marker
enzyme) (Fig. 3). The degree of
enrichment of the purified plasma membrane fraction with
G
i2 is similar to that for 5'-nucleotidase, indicating
that, as shown previously (12), considerable G
i2 is
located at the plasma membrane of hepatocytes. A small amount of
glucose-6-phosphatase activity was found to be associated with the
purified plasma membrane fraction. This may reflect either
contamination of the plasma membrane fraction with microsomes derived
from the ER or the attachment of small regions of the ER to the plasma
membrane (cf. Ref. 24).

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 3.
The relative distribution of 41-kDa
G i2, 43-kDa
G i2, and the plasma membrane
(5'-nucleotidase) and endoplasmic reticulum (glucose-6-phosphatase)
markers in subcellular fractions of rat liver. The homogenization
of rat liver; preparation of subcellular fractions; and determination
of protein concentration, relative amounts of 41-kDa G i2
and 43-kDa G i2 (by Western blot analysis and
densitometry), and marker enzyme activity were conducted as described
under "Experimental Procedures." The degree of enrichment of a
given fraction by G i2 or marker enzyme was determined by
dividing the amount of G i2 (densitometry units) or
marker enzyme (enzyme units) per mg of protein in the given subcellular
fraction by the amount of G i2 or marker enzyme per mg of
protein in the total homogenate. The results are the means ± S.E.
of three separate experiments involving separate rat liver
homogenates.
|
|
The degree of enrichment of the heavy and light microsomal fractions
with G
i2 is similar to that for glucose-6-phosphatase (Fig. 3). Consideration of the degrees of enrichment of these two
fractions with 5'-nucleotidase, together with the observation that the
purified plasma membrane fraction is equally enriched in
5'-nucleotidase and G
i2, indicates that the presence of
G
i2 in the microsomal fractions is unlikely to be due to
the contamination of these fractions by plasma membrane vesicles. The
total amounts of phosphorylated G
i2 and
G
i2 in the cytosolic fraction were estimated to be
84 ± 5 and 13 ± 3% (means ± S.E., n = 3 rat livers), respectively, of the total amount present in the homogenate.
Evidence for the Association of G
i2 and Actin in a
Purified Rat Liver Plasma Membrane Fraction--
It has previously
been shown that a purified liver plasma membrane fraction (prepared in
a manner similar to that described above) contains F-actin, which is
attached to the plasma membrane (35). Experiments were undertaken to
determine whether G
i2 is associated with this plasma
membrane-associated actin. First, the quality of the plasma membrane
fraction was further assessed by electron microscopy (Fig.
4). This showed numerous extended sheets
of membrane (large arrow), the presence of small
vesicles adherent to some sheets (small arrows),
and numerous other vesicles of varying size. The preparation was
largely free of mitochondria and nuclei.

View larger version (79K):
[in this window]
[in a new window]
|
Fig. 4.
Electron micrograph of a purified liver
plasma membrane fraction. The preparation of a plasma membrane
fraction from rat liver, processing of the fraction for electron
microscopy, and transmission electron microscopy were performed as
described under "Experimental Procedures." Scale
bar, 500 nm. The image shown is representative of
10 electron micrographs from two different membrane preparations.
|
|
The plasma membrane fraction was treated with 1% (w/v) Triton X-100 to
solubilize membrane lipids and integral proteins and thereby to obtain,
by centrifugation, a plasma membrane Triton X-100-insoluble pellet
enriched in F-actin and other cytoskeletal components (15).
G
i2 and actin were detected by Western blotting in both
the Triton X-100-insoluble pellet (predominantly F-actin) and the
Triton X-100-soluble supernatant (predominantly G-actin) (Fig.
5). It was estimated by densitometric
analysis that approximately 27 ± 3% (mean ± S.E.,
n = 4) of the total plasma membrane G
i2 and approximately 45 ± 1% (mean ± S.E., n = 3) of the total plasma membrane actin were recovered in the plasma
membrane Triton X-100-insoluble pellet.

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 5.
Western blot analysis of 41-kDa
G i2 and actin present in Triton
X-100 extracts and a repolymerized actin fraction obtained from a
purified liver plasma membrane preparation. Samples (15 µg of
protein) of a purified plasma membrane preparation (lane
1), a plasma membrane Triton X-100-insoluble pellet
(lane 2), a plasma membrane Triton X-100-soluble
supernatant (lane 3), and a repolymerized F-actin
fraction (lane 4) were subjected to SDS-PAGE and
Western blot analysis using an anti-G i antibody and an
anti-actin antibody. The preparation of a purified plasma membrane
fraction, treatment of the plasma membrane fraction with Triton X-100
to obtain an insoluble pellet and a soluble supernatant, and
depolymerization and repolymerization of F-actin were conducted as
described under "Experimental Procedures." The results shown are
from one of three experiments each of which gave similar results.
|
|
To further test that G
i2 associates specifically with
F-actin among the various cytoskeletal components of the plasma
membrane, a repolymerized F-actin fraction was prepared from the plasma membrane Triton X-100-insoluble pellet by a two-step
depolymerization-polymerization procedure (15). Analysis by SDS-PAGE
and Western blotting with anti-G
i and anti-actin
antibodies demonstrated the presence of G
i2 in the
repolymerized F-actin fraction (Fig. 5, lane 4).
Approximately 44 ± 0% of the G
i2 and 47 ± 2% of the actin in the plasma membrane Triton X-100-insoluble pellet
were recovered in the final repolymerized F-actin fraction. This
corresponds to 12 ± 0 and 21 ± 1% (means ± S.E.,
n = 3) of the total plasma membrane G
i2
and actin, respectively.
The idea that G
i2 and actin associate near the plasma
membrane was also investigated using a co-immunoprecipitation approach. When an anti-G
i antibody was used to precipitate
G
i2 from the Triton X-100-soluble supernatant of the
purified plasma membrane fraction, the precipitate was found to contain
actin, identified using an anti-actin antibody and Western blot
analysis (Fig. 6A). When an
anti-actin antibody was used to precipitate actin from the Triton
X-100-soluble supernatant of the purified plasma membrane fraction, the
precipitate was found to contain G
i2, identified using
an anti-G
i antibody and Western blot analysis (Fig.
6B). When a similar co-immunoprecipitation experiment was
performed with a liver cytosolic fraction (which is enriched in
phosphorylated G
i2), no co-immunoprecipitation of
phosphorylated G
i2 and actin was observed (data not
shown).

View larger version (31K):
[in this window]
[in a new window]
|
Fig. 6.
Western blot analysis of
anti-G i and anti-actin
immunoprecipitates from a Triton X-100-soluble supernatant prepared
from a purified liver plasma membrane fraction. A plasma membrane
fraction was treated with Triton X-100 and centrifuged to obtain a
Triton X-100-soluble supernatant. A, co-immunoprecipitation
of actin by an anti-G i antibody. The Triton
X-100-soluble supernatant was treated with anti-G i
antibody (lane 1) or normal rabbit serum as a
control (lane 2), as described under
"Experimental Procedures." Immunoprecipitates were resolved by
SDS-PAGE, Western blotted, and probed first with an
anti-G i antibody and subsequently an anti-actin
antibody. B, co-immunoprecipitation of 41-kDa
G i2 by an anti-actin antibody. The Triton X-100-soluble
supernatant was treated with anti-actin antibody (lane
1) or normal rabbit serum as a control (lane
2) as described under "Experimental Procedures."
Immunoprecipitates were resolved by SDS-PAGE, Western blotted, and
probed with first anti-G i antibody and subsequently with
an anti-actin antibody. The upper band labeled IgG HC is
immunoglobulin heavy chain. The results shown are those from one of two
experiments, each of which gave similar results.
|
|
Distribution of F-actin and G
i2 in Hepatocytes in
Primary Culture--
The intracellular distribution of
G
i2 and F-actin and the interaction between these
proteins was further investigated using hepatocytes attached to
collagen-coated coverslips, and Texas Red-X phalloidin and
immunofluorescence to detect F-actin and G
i2,
respectively. In freshly isolated rat hepatocytes allowed to attach to
coverslips for 0.5 h, F-actin was observed around the cortex, in
both single hepatocytes and in hepatocyte doublets (Fig.
7A). When cultured for a
further 3.5 h, the amount of F-actin in single cells and in
doublets decreased in most regions of the cortex. In single cells,
areas of high F-actin remained in some small regions of the cortex. In
doublets, a pronounced concentration of F-actin at the canalicular
membranes was observed (Fig. 7C). This most likely
corresponds to the re-establishment of F-actin polarity and cell
polarity, as described previously (32, 36). Hepatocytes cultured for
4 h appeared to be more flattened and to have a larger diameter
compared with cells cultured for 0.5 h (Fig. 7, compare
C with A).

View larger version (61K):
[in this window]
[in a new window]
|
Fig. 7.
The distribution of F-actin and
G i2 monitored using fluorescence
microscopy, in hepatocytes derived from control and pertussis
toxin-treated rats. Hepatocytes derived from vehicle-treated rats
(Control) and rats treated with pertussis toxin
(PTX) were cultured for 0.5 or 4 h, and the locations
of F-actin (using Texas Red-X phalloidin) or G i2 (using
immunofluorescence) were determined as described under "Experimental
Procedures." Panels I and J are
images obtained when the anti-G i antibody was omitted
from the procedure used to detect G i2. Images were
obtained by confocal microscopy. The scale bars
correspond to 20 µm. The images shown are representative of more than
300 cells examined from three separate control and pertussis
toxin-treated cell preparations.
|
|
Substantial amounts of G
i2 (presumably both
phosphorylated and nonphosphorylated forms) were found in the
cytoplasmic space as well as at the plasma membrane of most hepatocytes
examined, as shown previously (10, 12) (Fig. 7, E and
G). In order to investigate the possible co-localization of
G
i2 and F-actin, hepatocytes were double stained with
Texas Red-X phalloidin and anti-G
i antibody (Fig.
8, A-C). The results indicate
that there are regions of the cortex where the fluorescence signals
representing G
i2 and F-actin overlap (indicated by the
orange-yellow regions in Fig. 8C).

View larger version (46K):
[in this window]
[in a new window]
|
Fig. 8.
The localization of F-actin and
G i2 in hepatocytes. Freshly
isolated hepatocytes from untreated rats were cultured for 0.5 h,
fixed, stained first for F-actin with Texas Red-X phalloidin
(A), incubated with primary and secondary antibodies for the
detection of G i2 (B), and then examined by
confocal microscopy, as described under "Experimental Procedures."
C, images in A and B are
superimposed, revealing regions of double labeling, indicated by
orange-yellow color. Scale bars, 20 µm. The images shown are representative of more than 100 cells examined from two separate cell preparations.
|
|
Effects of the Ablation of G
i2 Function by
Pretreatment with Pertussis Toxin on the Intracellular Distribution of
F-actin, G
i2, and the Endoplasmic Reticulum and the
Activation of Ca2+ Inflow--
In order to further
elucidate the role of G
i2 in regulation of the
arrangement of the actin cytoskeleton and to study the roles of
G
i2 and F-actin in the activation of SOCs, the treatment of rats with pertussis toxin was used to ablate G
i2
function. The effectiveness of pertussis toxin treatment was assessed
by determining the degree of ADP-ribosylation of G
i2,
using SDS-PAGE in the presence of 6 M urea to identify
ADP-ribosylated G
i2 (23). Pertussis toxin treatment
caused ADP-ribosylation of G
i2, as shown by the
appearance of a new band in the urea/SDS-PAGE gel with a slower
mobility than that of G
i2 (Fig.
9). Treatment with pertussis toxin did
not result in any change in the mobility of the phosphorylated (43-kDa)
G
i2 band (results not shown). The slower band
(ADP-ribosylated G
i2) was observed in the plasma membrane fraction (Fig. 9A, lower
panel, lane 2), the plasma membrane Triton X-100-insoluble pellet (lane 4), the
plasma membrane Triton X-100-soluble supernatant (lane
6), and the heavy and light microsomal fractions (Fig.
9B). Quantitation of the bands using densitometry showed
that pertussis toxin treatment resulted in ADP-ribosylation of 60, 80, and 50% of G
i2 in the total plasma membrane fraction, the plasma membrane Triton X-100-insoluble pellet, and the plasma membrane Triton X-100-soluble supernatant, respectively, and
approximately 70% of G
i2 associated with the heavy plus
the light microsomes.

View larger version (40K):
[in this window]
[in a new window]
|
Fig. 9.
Effects of pertussis toxin pretreatment on
the degree of ADP-ribosylation of plasma membrane (A)
and microsomal (B)
G i2, assessed by
SDS-PAGE in the presence of urea. A purified plasma membrane
fraction, a plasma membrane Triton X-100-insoluble pellet, a plasma
membrane Triton X-100-soluble supernatant, and heavy and light
microsomal fractions were prepared from the livers of control and
pertussis toxin-treated rats as described under "Experimental
Procedures." Samples (15 µg of protein for plasma membrane
fractions and 20 µg of protein for microsomal fractions) were
subjected to either SDS-PAGE (A, upper
panel) or SDS-PAGE in the presence of 6 M urea
(A, lower panel, and B) and
Western blotted, and actin and G i2 were detected using
either an anti-actin antibody or an anti-G i antibody.
The results shown are those obtained from three separate experiments
that each gave similar results.
|
|
Pertussis toxin pretreatment caused no detectable changes in the total
amount of actin in the plasma membrane fraction (Fig. 9A,
upper panel, compare lane 2 with lane 1). Further, since the Triton
X-100-insoluble pellet contains predominantly F-actin and the Triton
X-100-soluble supernatant contains mainly G-actin (6, 15), the results
also indicated that pertussis toxin treatment did not change the
relative distribution of the two forms of actin in the plasma membrane
fraction (Fig. 9A, upper panel,
compare lane 4 with lane 3 for F-actin; compare lane 6 with lane
5 for G-actin).
Cells from rats treated with pertussis toxin (pertussis toxin-treated
cells) that had been cultured for 0.5 h exhibited no substantial
differences in the intracellular distribution of F-actin compared with
cells from vehicle-treated rats (control cells) cultured for this time
(Fig. 7, compare B and A). However, the treatment
with pertussis toxin prevented the redistribution of F-actin from the
cortex to the bile canaliculus and other parts of the cell
observed in control cells cultured for 4 h (Fig. 7, compare
D and C). To quantitatively compare the
differences in the distribution of F-actin in 4-h cultured doublets
from control and pertussis toxin-treated rats, the pericanalicular
fluorescence due to the F-actin-Texas Red-X phalloidin complex was
expressed as a percentage of the total doublet fluorescence. This value was 18.87 ± 0.70% (mean ± S.E., n = 60) in
control doublets compared with 11.27 ± 0.26% (mean ± S.E.,
n = 60) in pertussis toxin-treated doublets
(p < 0.001, heteroscedastic t test).
Pertussis toxin treatment also inhibited the spreading of cells
observed at 4 h (Fig. 7, compare D and C).
Thus, the total doublet area was 1153 ± 49 µm2
(mean ± S.E., n = 60) in control doublets
compared with 936 ± 25 µm2 (mean ± S.E.,
n = 60) in pertussis toxin-treated doublets
(p < 0.001, heteroscedastic t test).
Pertussis toxin-treated hepatocytes cultured for both 0.5 and 4 h
exhibited noticeable differences in the distribution of G
i2 (Fig. 7, compare F and E;
compare H and G). In contrast to control cells,
where considerable G
i2 was present in the cytoplasmic space as well as at the plasma membrane, in pertussis toxin-treated cells, G
i2 was principally located at the plasma
membrane and in the cortical region (Fig. 7, compare F and
H with E and G).
Pertussis toxin-treated hepatocytes exhibited more intense staining of
the ER, monitored using DiOC6(3), than that observed in
control cells (Figs. 10, compare
B and D with A and C).
Moreover, the DiOC6(3) signal was more evenly distributed
in pertussis toxin-treated cells. These differences were observed in
cells cultured for both 0.5 and 4 h. Examination of the cells by
electron microscopy revealed that pertussis toxin-treated hepatocytes
had largely lost the regular parallel arrangement of sheets of rough ER
that were observed in control hepatocytes (Fig.
11, compare B and
A). These differences can be seen more clearly at higher
magnification (Fig. 11, compare D and C).
Moreover, in pertussis toxin-treated cells the smooth ER appeared
less dense than that in control hepatocytes (Fig. 11, compare
B and A).

View larger version (93K):
[in this window]
[in a new window]
|
Fig. 10.
Fluorescence micrographs of the nature and
location of the endoplasmic reticulum, determined using
DiOC6(3), in hepatocytes from control rats and rats treated
with pertussis toxin. Hepatocytes were isolated from pertussis
toxin-treated and control rats, grown on collagen-coated coverslips for
either 0.5 or 4 h, fixed, stained with DiOC6(3), and
examined by confocal microscopy as described under "Experimental
Procedures." Scale bar, 20 µm. The
images shown are representative of more than 60 cells
examined from three separate cell preparations.
|
|

View larger version (156K):
[in this window]
[in a new window]
|
Fig. 11.
Electron micrographs of hepatocytes from
control rats and rats treated with pertussis toxin. Hepatocytes
were isolated from pertussis toxin-treated and control rats, fixed, and
processed and examined by electron microscopy as described under
"Experimental Procedures." Scale bars, 5 µm
(A and B) and 500 nm (C and
D). The images of control cells
(Control) are representative of 33 out of 35 individual
control hepatocytes examined from two separate cell preparations. The
images of pertussis toxin-treated cells (PTX) are
representative of 37 out of 44 individual pertussis toxin-treated
hepatocytes examined from two separate cell preparations.
|
|
As shown previously, treatment with pertussis toxin inhibited
vasopressin-stimulated Ca2+ inflow (Fig.
12). There was no detectable effect of
pertussis toxin treatment on vasopressin-induced release of
Ca2+ from intracellular stores (results not shown).

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 12.
The effect of pretreatment with pertussis
toxin on vasopressin-stimulated Ca2+ inflow. The
isolation of hepatocytes from rats treated with pertussis toxin
(B) or vehicle (A) and the measurement of
Ca2+ inflow in single hepatocytes were performed as
described under "Experimental Procedures." The additions of
vasopressin (40 nM) and Ca2+ (1.5 mM) were made as indicated by the horizontal
bars. Each trace is representative of those
obtained for 5-13 individual cells from two separate hepatocyte
preparations.
|
|
 |
DISCUSSION |
Role of Gi2 in Regulating the Organization of F-actin
and the Endoplasmic Reticulum--
In keeping with the observations of
others (37), a 43-kDa phosphorylated form of G
i2 as well
as the nonphosphorylated 41-kDa form were detected in hepatocytes. The
present study has focused on G
i2 (the 41-kDa form),
which is bound to the plasma membrane and ER (microsomes), rather than
on the phosphorylated 43-kDa G
i2, for the following
reasons: (i) the phosphorylated G
i2 is hardly detectable
in the plasma membrane fraction and is only loosely associated with the
microsomes, (ii) there was no evidence from co-immunoprecipitation
studies of an association between actin and phosphorylated
G
i2, and (iii) there was no evidence that the
phosphorylated G
i2 was ADP-ribosylated by pertussis toxin treatment.
The following observations indicate that G
i2 (the 41-kDa
form) associates with actin at the periphery of the hepatocyte: (i) the
detection of both G
i2 and F-actin in a Triton
X-100-insoluble pellet prepared from a highly purified liver plasma
membrane fraction; (ii) the detection of G
i2 in
repolymerized actin obtained after F-actin in the plasma membrane
Triton X-100-insoluble fraction was de-polymerized and re-polymerized;
(iii) co-precipitation of G
i2 and actin from the plasma
membrane Triton X-100-soluble fraction using either an
anti-G
i antibody or an anti-actin antibody; and (iv) the
observed co-localization of some G
i2 and F-actin at the
cell periphery.
The results of experiments that employed pertussis toxin to ablate the
action of G
i2 indicate that this trimeric G-protein is
involved in regulating the organization of cortical F-actin in
hepatocytes. Pertussis toxin specifically ADP-ribosylates and inactivates the
subunit of Gi1, Gi2,
Gi3, Go, and transducin (38). Since neither
transducin, Go, nor G
i1 is expressed at detectable levels in hepatocytes (19, 20), G
i2 and
G
i3 are the only two known targets for pertussis toxin
in these cells. Moreover, there is evidence that the time course for
ADP-ribosylation of G
i3 by pertussis toxin treatment
in vivo (72 h) is longer than that for G
i2
(24-48 h) (23). Therefore, the in vivo pertussis toxin
treatment employed in this study (24 h) is likely to result chiefly in
inactivation of G
i2. Moreover, urea/SDS-PAGE and Western blotting confirmed that the majority of the G
i2 on the
plasma membrane, in particular the G
i2 associated with
F-actin, was ADP-ribosylated and hence inactivated. It is clear from
our results that this pertussis toxin treatment inhibited the
redistribution of F-actin from the cortex to the bile canaliculus in
hepatocyte doublets and the redistribution of F-actin to specific
regions of the plasma membrane in single hepatocytes. Normally, cell
polarity, which is lost during isolation of hepatocytes, can be
restored within 3-4 h in monolayer culture (36). This re-establishment of cell polarity has been found to be closely associated with the
redistribution of F-actin from the entire cortex to the canalicular pole (i.e. the polarization of F-actin) (32). The present
results indicate that Gi2 may be part of the machinery that
governs the maintenance of a polarized distribution of F-actin in
hepatocytes. The observation that pertussis toxin pretreatment
prevented the spreading of hepatocytes in primary culture provides
further evidence that Gi2 regulates F-actin organization,
since it has been shown that hepatocyte spreading in culture requires
F-actin organization (39).
Studies with several other types of cells have also shown that
Gi2 interacts with F-actin (13-15) and is likely to play a
role in regulating the organization of F-actin (16-18). For example, the degree of actin polymerization in differentiating U937 cells was
found to correlate well with an increase in the amount of G
i2 at the plasma membrane (16). In human airway smooth
muscle cells, it has been shown that G
i2 is required for
carbachol-induced stress fiber formation (18). In experiments employing
pertussis toxin, evidence has also been obtained that the dysfunction
of G
i causes a 40-50% decrease in the cortical F-actin
content in chromaffin cells (40) and diminishes fMet-Leu-Phe-induced
actin polymerization in neutrophils (41). Furthermore, evidence for a
link between the activity of G
i, the basal concentration
of intracellular cyclic AMP, and the assembly of stress fibers in primary human granulosa-lutein cells has recently been reported (42).
These observations, together with our present results with hepatocytes,
suggest that trimeric G-proteins such as Gi2 are involved
in regulating the organization of the actin cytoskeleton in a variety
of cell types.
Pertussis toxin treatment also caused fragmentation and redistribution
of the ER, detected using DiOC6(3) and fluorescence microscopy and by electron microscopy. Furthermore, 40% of the total
cellular G
i2 was found to be associated with microsomes, and approximately 70% of microsome-associated G
i2 was
ADP-ribosylated by pertussis toxin treatment. These results indicate
that Gi2 is likely to be directly or indirectly involved in
regulating the structure and intracellular distribution of the ER in
hepatocytes. Moreover, considering the evidence of Hajnóczky
et al. (43) that the luminal communication between
intracellular Ca2+ stores is cooperatively modulated by GTP
and the cytoskeleton, an intriguing possibility is that Gi2
is involved in maintaining the luminal continuity of the ER in
hepatocytes, either via the actin cytoskeleton or by interaction with
other proteins.
Pertussis toxin treatment caused a noticeable redistribution of
G
i2 immunofluorescence from the cytoplasmic space to the cell periphery. This observation may reflect the redistribution of some
G
i2 from the cytoplasmic space to the cell periphery. However, others have shown, using Western blotting, that compared with
native G
i2, ADP-ribosylated G
i2 has a
higher affinity for the anti-G
i antibody employed in the
present studies (44). Therefore, some of the substantial increase in
G
i2 immunofluorescence at the cortex of pertussis
toxin-treated hepatocytes may be due to an enhanced affinity of the
anti-G
i antibody for ADP-ribosylated G
i2
(compared with native G
i2).
Role of Actin and Gi2 in Activation of Ca2+
Inflow--
Pertussis toxin treatment caused a substantial inhibition
of vasopressin-induced Ca2+ inflow with little effect on
vasopressin-induced release of Ca2+ from intracellular
stores (present and previous (30) results). Previous studies have shown
that pertussis toxin treatment completely inhibits thapsigargin-induced
Ca2+ inflow without a substantial effect on
thapsigargin-induced release of Ca2+ from the ER (45) and
have shown that the effects of pertussis toxin can be mimicked by the
microinjection of an anti-G
i2 antibody or peptide
corresponding to the carboxyl region of G
i2, which inhibits Gi2 function (10). These results provided
substantial evidence to indicate that Gi2 (rather than
Gi3, which is also present in rat hepatocytes and can be
ADP-ribosylated by pertussis toxin (20, 38)) is necessary for the
activation of SOCs in rat hepatocytes (10). Moreover, the previous
experiments also indicate that the ablation of G
i2
action by pertussis toxin does not substantially affect the formation
of InsP3 catalyzed by phospholipase C
, the interaction
of InsP3 with InsP3 receptors, the ability of
InsP3 receptors to release Ca2+ from most
regions of the ER, or the interaction of thapsigargin with the ER
(Ca2+ + Mg2+)-ATPase and the inhibition of this
Ca2+ pump. (The possibility that ablation of
G
i2 affects the release of Ca2+ from a small
region of the ER near the plasma membrane that is central to the
activation of SOCs but was not detected as a reduction in
vasopressin-induced release of Ca2+ from intracellular
stores cannot be excluded.)
The present results show that two of the functions of Gi2
in hepatocytes are to regulate F-actin assembly at the cortex and arrangement of the ER. It is possible that one or both of these functions is essential for the activation of SOCs. Thus, as suggested by others, the activation of SOCs may require maintenance of a region
of the ER near the plasma membrane (e.g. "docking" of
regions of the ER with the plasma membrane and/or the fusion of
vesicles containing SOC proteins with the plasma membrane (6, 46)). In
this respect, it is interesting to note that the effects of G
i2 ablation (pertussis toxin treatment) in stabilizing
F-actin at the hepatocyte cortex and inhibiting SOC activation are
similar to results recently reported by Patterson et al.
(6). These authors showed that, in a smooth muscle cell line, the
stabilization of F-actin by different procedures (treatment with
jasplakinolide or calyculin A, which induced the formation of a dense
ring of F-actin around the cell periphery) also inhibited SOC
activation (6).
A requirement for Gi2 in the activation of SOCs has not
been reported in studies of most other mammalian cells (47). This suggests that the requirement for Gi2 in SOC activation in
hepatocytes (10) reflects one or more aspects of the specific structure and function of these cells, such as maintenance (via Gi2
regulation of the actin cytoskeleton or interaction of Gi2
with another ER-associated protein) of cell polarity and/or a specific
distribution of the ER throughout the cell, which is critical for the
activation of SOCs. This may be due to a requirement for
Gi2 in the regulation of F-actin organization that is more
accentuated in hepatocytes than in other cell types. Another
possibility is that, in the hepatocyte, the InsP3 receptors
principally involved in inducing a decrease in Ca2+ in the
lumen of the ER are located some distance from the SOCs so that normal
intraluminal communication through the ER is required for SOC
activation (cf. Ref. 48).
 |
ACKNOWLEDGEMENTS |
We gratefully acknowledge Dr. Michael Crouch
(Australian National University) for providing anti-G
i
antibody, Dr. Alistair Sim (University of Newcastle) for gifts of
purified phosphoprotein phosphatase 1 and phosphoprotein phosphatase
2A, Dr. Peter Kolesik (University of Adelaide) for performing the
confocal microscopy, and Kerry Gascoigne and Dr. Chris Lunam
(Department of Anatomy and Histology, Flinders University) for
assistance with electron microscopy. We thank David Doherty for the
preparation of hepatocytes and Diana Tanevski for the preparation of
the typescript.
 |
FOOTNOTES |
*
This work was supported by a grant from the National Health
and Medical Research Council of Australia.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Recipient of an Australian Overseas Postgraduate Research
Scholarship and a Flinders University Research Scholarship.
§
To whom correspondence should be addressed. Tel.: 61 8 8204 4260;
Fax: 61 8 8374 0139; E-mail: Greg.Barritt@flinders.edu.au.
Published, JBC Papers in Press, April 27, 2000, DOI 10.1074/jbc.M001563200
 |
ABBREVIATIONS |
The abbreviations used are:
InsP3, inositol 1,4,5-trisphosphate;
SOC, store-operated Ca2+
channel;
ER, endoplasmic reticulum;
DiOC6(3), 3,3'-dihexyloxacarbocyanine iodide;
PAGE, polyacrylamide gel
electrophoresis;
F-actin, filamentous actin;
G-actin, globular
actin.
 |
REFERENCES |
| 1.
|
Putney, J. W., Jr.
(1997)
Capacitative Calcium Entry
, Landes Biomedical Publishing, Austin, TX
|
| 2.
|
Barritt, G. J.
(1999)
Biochem. J.
337,
153-169
|
| 3.
|
Putney, J. W., Jr.
(1999)
Cell
99,
5-8
|
| 4.
|
Rossier, M. F.,
Bird, G. S. J.,
and Putney, J. W., Jr.
(1991)
Biochem. J.
274,
643-650
|
| 5.
|
Holda, J. R.,
and Blatter, L. A.
(1997)
FEBS Lett.
403,
191-196
|
| 6.
|
Patterson, R. L.,
van Rossum, D. B.,
and Gill, D. L.
(1999)
Cell
98,
487-499
|
| 7.
|
Watanabe, H.,
Takahashi, R.,
Zhang, X.-X.,
Goto, Y.,
Hayashi, H.,
Ando, J.,
Isshiki, M.,
Seto, M.,
Hidaka, H.,
Niki, I.,
and Ohno, R.
(1998)
FASEB J.
12,
341-348
|
| 8.
|
Ribeiro, C. M. P.,
Reece, J.,
and Putney, J. W., Jr.
(1997)
J. Biol. Chem.
272,
26555-26561
|
| 9.
|
French, S. W.,
Cadrin, M.,
Kawahara, H.,
and Kachi, K.
(1993)
in
Molecular and Cellular Biology of the Liver
(LeBouton, A. V., ed)
, pp. 143-180, CRC Press, Inc., Boca Raton, FL
|
| 10.
|
Berven, L. A.,
Crouch, M. F.,
Katsis, F.,
Kemp, B. E.,
Harland, L. M.,
and Barritt, G. J.
(1995)
J. Biol. Chem.
270,
25893-25897
|
| 11.
|
Fernando, K. C.,
Gregory, R. B.,
Katsis, F.,
Kemp, B. E.,
and Barritt, G. J.
(1997)
Biochem. J.
328,
463-471
|
| 12.
|
Cadrin, M.,
McFarlane-Anderson, N.,
Harper, M.-E.,
Gaffield, J.,
and Bégin-Heick, N.
(1996)
J. Cell. Biochem.
62,
334-341
|
| 13.
| |